Comparative Analysis of Ocular Adverse Events Associated with Aflibercept 8 mg and Faricimab: A Global Population-Based Study Across 65 Countries

Macular DiseasesRetinal Diseases

Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study: Ocular Adverse Events of Pegcetacoplan & Avacincaptad Pegol

Am J Ophthalmol

Kailani Z, Mihalache A, Popovic MM, Kertes PJ, Muni RH

doi: 10.1016/j.ajo.2025.04.022

Macular DiseasesRetinal Diseases

Association of Anti-VEGF Therapy with Reported Ocular Adverse Events: A Global Pharmacovigilance Analysis

Ophthalmol Retina

Lakhani M, Kwan ATH, Kundapur D, Popovic MM, Damji KF, Hurley BR

doi: 10.1016/j.oret.2025.08.018

Further Publications

Drugs Associated with Floppy Iris Syndrome: A Real-World Population-Based Study: Drugs Associated with Floppy Iris Syndrome

Am J Ophthalmol

Lakhani M, Kwan ATH, Mihalache A, Popovic MM, Hurley B, Muni RH

doi: 10.1016/j.ajo.2025.03.023

Retinal Diseases

Ocular Adverse Events With Semaglutide: A Systematic Review and Meta-Analysis

JAMA Ophthalmol

Natividade GR, Spiazzi BF, Baumgarten MW, Bassotto C, Pereira AA, Fraga BL, Scalco BG, Mattes NR, Lavinsky D, Kramer CK, Gerchman F

doi: 10.1001/jamaophthalmol.2025.2489

Macular Diseases

Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration

J Clin Med

Hatz K, Ambresin A, Schmid M, Prünte C, Barthelmes D, Machewitz T, Allmeier H, Somfai GM, XTEND Study Group

doi: 10.3390/jcm14072370

Retinal DiseasesFurther Publications

Global demographic and etiological variations of retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 1

Surv Ophthalmol

Cifuentes-González C, Le Tong Y, Mejía-Salgado G, Chan R, Walter CFY, Rojas-Carabali W, Putera I, Mobasserian A, Nora RD, Biswas J, Gangaputra S, Pulido JS, Kempen JH, Nguyen QD, de la Torre A, Gupta V, Rosenbaum JT, Agrawal R, REVISE-IUSG study group

doi: 10.1016/j.survophthal.2025.01.012

Blindness and Vision ImpairmentCataracts

Global trends in cataract burden: a 30-year epidemiological analysis and prediction of 2050 from the Global Burden of Disease 2021 study

Br J Ophthalmol

Jiang X, Xu B, Zhai J, Huang S, Cheng H, Ma L, Zhao YE

doi: 10.1136/bjo-2025-327776

Retinal Diseases

Clinical characteristics associated with complications and poor visual outcomes in ocular toxoplasmosis: Analysis of 853 patients: complications and visual outcomes in ocular toxoplasmosis

Am J Ophthalmol

de-la-Torre A, Mejía-Salgado G, Cifuentes-González C, Cuevas M, García S, Rangel CM, Durán C, Pachón-Suárez DI, Bustamante-Arias A, Rojas-Carabali W

doi: 10.1016/j.ajo.2025.02.027

Retinal DiseasesFurther Publications

Comparative efficacy of photodynamic therapy (PDT), ranibizumab, aflibercept monotherapy, and combination therapies for polypoidal choroidal vasculopathy: a network meta-analysis of randomized controlled trials

BMC Ophthalmol

Quiroz-Reyes MA, Quiroz-Gonzalez EA, Quiroz-Gonzalez MA, Lima-Gomez V

doi: 10.1186/s12886-025-04249-8

Related content

Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study: Ocular Adverse Events of Pegcetacoplan & Avacincaptad Pegol

Association of Anti-VEGF Therapy with Reported Ocular Adverse Events: A Global Pharmacovigilance Analysis

Drugs Associated with Floppy Iris Syndrome: A Real-World Population-Based Study: Drugs Associated with Floppy Iris Syndrome

Ocular Adverse Events With Semaglutide: A Systematic Review and Meta-Analysis

Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration

Global demographic and etiological variations of retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 1

Global trends in cataract burden: a 30-year epidemiological analysis and prediction of 2050 from the Global Burden of Disease 2021 study

Clinical characteristics associated with complications and poor visual outcomes in ocular toxoplasmosis: Analysis of 853 patients: complications and visual outcomes in ocular toxoplasmosis

Comparative efficacy of photodynamic therapy (PDT), ranibizumab, aflibercept monotherapy, and combination therapies for polypoidal choroidal vasculopathy: a network meta-analysis of randomized controlled trials